What are the normal glucose levels for a post-partum Glucose Tolerance Test (GTT) in Canada?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Values for Post-Partum Glucose Tolerance Test in Canada

Women with a history of gestational diabetes mellitus (GDM) should be tested for prediabetes or diabetes 4-12 weeks postpartum using a 75-g oral glucose tolerance test (OGTT) with the following non-pregnancy diagnostic criteria: fasting plasma glucose ≥7.0 mmol/L (126 mg/dL) or 2-hour plasma glucose ≥11.1 mmol/L (200 mg/dL) for diabetes diagnosis. 1

Post-Partum GTT Diagnostic Criteria

The post-partum OGTT uses standard non-pregnancy criteria to identify persistent glucose abnormalities:

Normal Values:

  • Fasting plasma glucose: <6.1 mmol/L (<110 mg/dL)
  • 2-hour plasma glucose: <7.8 mmol/L (<140 mg/dL)

Prediabetes Values:

  • Impaired fasting glucose (IFG): 6.1-6.9 mmol/L (110-125 mg/dL)
  • Impaired glucose tolerance (IGT): 2-hour plasma glucose 7.8-11.0 mmol/L (140-199 mg/dL)

Diabetes Values:

  • Fasting plasma glucose: ≥7.0 mmol/L (≥126 mg/dL) OR
  • 2-hour plasma glucose: ≥11.1 mmol/L (≥200 mg/dL)

Timing of Post-Partum Testing

The 75-g OGTT should be performed at 4-12 weeks postpartum 1. This timing is critical because:

  • Earlier testing (2-4 days postpartum) may have good specificity but lower sensitivity for detecting glucose abnormalities 2
  • HbA1c is not recommended at this visit because the concentration may still be influenced by pregnancy-related changes and peripartum blood loss 1

Importance of Using OGTT vs. Fasting Glucose Alone

The complete 75-g OGTT (not just fasting glucose) is strongly recommended because:

  • Using fasting plasma glucose alone detects only 15.8% of women with any glucose abnormality postpartum 3
  • The 2-hour post-glucose load value detects 97.5% of abnormalities 3
  • Fasting plasma glucose alone fails to detect IGT or diabetes in 39% of cases 3

Follow-Up Testing After Initial Post-Partum GTT

For women with a history of GDM:

  • If initial post-partum GTT is normal: lifelong screening for diabetes every 1-3 years 1
  • Follow-up testing can use any recommended glycemic test (annual HbA1c, annual fasting plasma glucose, or triennial 75-g OGTT) 1

Clinical Implications

Women with GDM have a significantly increased lifetime risk of developing type 2 diabetes:

  • 20% at 10 years
  • 30% at 20 years
  • 40% at 30 years
  • 50% at 40 years
  • 60% at 50 years 1

This underscores the importance of proper post-partum testing and long-term follow-up to identify diabetes early and implement preventive strategies.

Common Pitfalls to Avoid

  1. Relying solely on fasting glucose: This misses many cases of glucose intolerance and diabetes 3
  2. Using HbA1c for initial post-partum testing: Pregnancy-related changes affect HbA1c values 1
  3. Poor follow-up rates: Only about 50% of women return for the recommended 6-12 week post-partum testing 2, 4
  4. Ignoring women with only one abnormal GTT value during pregnancy: These women still have increased risk compared to those with completely normal glucose tolerance 5

The complete OGTT at 4-12 weeks postpartum remains the gold standard for detecting persistent glucose abnormalities after GDM.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Early versus 6-12 week postpartum glucose tolerance testing for women with gestational diabetes.

Journal of perinatology : official journal of the California Perinatal Association, 2018

Research

The importance of a postpartum 75 g oral glucose tolerance test in women with gestational diabetes.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.